Paper688253
Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.
Chan KK and 6 others. Cancer Treat Rep, 1978. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model. Papers, record 688253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/688253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Doxorubicin | Major topic |
| Neoplasms | Major topic |
| Animals | |
| Humans | |
| Kinetics | |
| Models, Biological | |
| Rabbits |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26744621 | Synergistic interaction between lipid-loading and doxorubicin exposure in Huh7 hepatoma cells results in enhanced cytotoxicity and cellular oxidative stress: implications for acute and chronic care of obese cancer patients. | Toxicol Res (Camb) | 2015 | https://conductscience.org/library/papers/26744621 | PubMed |
| 23616082 | Incorporation of ABCB1-mediated transport into a physiologically-based pharmacokinetic model of docetaxel in mice. | J Pharmacokinet Pharmacodyn | 2013 | https://conductscience.org/library/papers/23616082 | PubMed |
| 23315145 | Physiologically based pharmacokinetic model of lapatinib developed in mice and scaled to humans. | J Pharmacokinet Pharmacodyn | 2013 | https://conductscience.org/library/papers/23315145 | PubMed |
| 21756913 | β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways. | J Mol Cell Cardiol | 2011 | https://conductscience.org/library/papers/21756913 | PubMed |
| 11587492 | A physiologically based pharmacokinetic analysis of capecitabine, a triple prodrug of 5-FU, in humans: the mechanism for tumor-selective accumulation of 5-FU. | Pharm Res | 2001 | https://conductscience.org/library/papers/11587492 | PubMed |
| 11005567 | A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells. | Neoplasia | 2000 | https://conductscience.org/library/papers/11005567 | PubMed |
| 8763151 | Antibody-targeted polymer-bound drugs. | Folia Microbiol (Praha) | 1995 | https://conductscience.org/library/papers/8763151 | PubMed |
| 8137454 | Pharmacokinetics of doxorubicin and its active metabolite in patients with normal renal function and in patients on hemodialysis. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8137454 | PubMed |
| 7340990 | Tissue distribution of doxorubicin and doxorubicinol in rats receiving multiple doses of doxorubicin. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7340990 | PubMed |
| 7334460 | Development and identification of a multicompartment model for the distribution of adriamycin in the rat. | J Pharmacokinet Biopharm | 1981 | https://conductscience.org/library/papers/7334460 | PubMed |
| 7206588 | [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)]. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7206588 | PubMed |
| 7023712 | Dose-dependent pharmacokinetics and cancer chemotherapy. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7023712 | PubMed |
| 6940622 | Different distribution of adriamycin in normal and leukaemic rats. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6940622 | PubMed |
| 6659213 | Evaluation of cytostatic drug concentrations in the kidney, bladder wall, and prostate by means of the diffusion chamber technique in dogs. | Urol Res | 1983 | https://conductscience.org/library/papers/6659213 | PubMed |
| 6630285 | Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6630285 | PubMed |
| 6573906 | Distribution of 4'epi-doxorubicin in human tissues. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6573906 | PubMed |
| 6466545 | Effect of adriamycin on CFUGM at plasma concentrations found following therapeutic infusions. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6466545 | PubMed |
| 6102499 | Clinical relevance of pharmacokinetics. | Clin Pharmacokinet | 1980 | https://conductscience.org/library/papers/6102499 | PubMed |
| 3719895 | Serum and tissue concentrations of doxorubicin after IV administration of doxorubicin or doxorubicin-DNA complex to patients with gastrointestinal cancer. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3719895 | PubMed |
| 3718837 | Studies on the in vivo disposition of adriamycin in human tumours which exhibit different responses to the drug. | Br J Cancer | 1986 | https://conductscience.org/library/papers/3718837 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/688253
GET https://conductscience.org/api/papers/v1/688253/cited_by?page=2